Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 29, 2015Journal of Cardiovascular PharmacologyOpen Access

ACE2 and Microbiota

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

CCColleen T. Cole‐JeffreyRenji HospitalMLMeng LiuUniversity of JinanMKMichael J. KatovichUniversidade Federal de Minas Gerais

Discussion

Loading...

Member takes

Implication

Hypothesis-generating for ACE2-microbiota targeting in cardiopulmonary disease; prospective trials needed before clinical adoption.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cole‐Jeffrey et al. (2015) studied this question.

synapsesocial.com/papers/6a852749563dbb7b86d97c5ehttps://doi.org/10.1097/fjc.0000000000000307
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The ACE2 gene: its potential as a functional candidate for cardiovascular disease2012 · 94 citations
  2. 2Myocardial infarction increases ACE2 expression in rat and humans2005 · 428 citations
  3. 3Recombinant Angiotensin-Converting Enzyme 2 Suppresses Pulmonary Vasoconstriction in Acute Hypoxia2012 · 39 citations
  4. 4Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension2012 · 351 citations
  5. 5Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice2003 · 45 citations